MedPath

Effectiveness of Two Compression Methods in the Treatment of Upper Limb Lymphedema

Not Applicable
Completed
Conditions
Lymphedema
Interventions
Device: Precast Adjustable Compression Wrap (Circaid)
Device: Multilayer Compression Bandages
Registration Number
NCT02369679
Lead Sponsor
Parc de Salut Mar
Brief Summary

Treatment of lymphedema is based on a combined program called complex decongestive therapy. The components of the complex decongestive therapy are skin care, kinesiotherapy, manual lymphatic drainage and compression. The compression with multilayer bandage has proved to be the most effective of these therapies when analyzed separately.The multilayer bandage produces a gradient compression on the limb where distal pressure is higher than proximal pressure. Several materials are needed for the multilayer bandage, including tubular bandage lining, digit bandages, foam under-cast padding and multiple layers of short-stretch bandages to cover the entire limb. The Precast Adjustable Compression Wrap fits each patient through a Velcro system.

The aim is to compare the effectiveness of a precast adjustable compression wrap (Circaid) with the multilayer compression bandages in the treatment of the upper limb lymphedema.

Detailed Description

The gold standard of the treatment of lymphedema is based on a combined program called complex decongestive therapy. The components of the complex decongestive therapy are skin care, kinesiotherapy, manual lymphatic drainage and compression. The compression with multilayer bandage has proved to be the most effective of these therapies when analyzed separately. With the multilayer compression bandage the upper limb lymphedema volume decreased a 37.2%.

The multilayer bandage produces a gradient compression on the limb where distal pressure is higher than proximal pressure. Several materials are needed for the multilayer bandage, including tubular bandage lining, digit bandages, foam under-cast padding and multiple layers of short-stretch bandages to cover the entire limb. The Precast Adjustable Compression Wrap fits each patient through a Velcro system.

Decreasing compression is achieved by controlling the tension applied to each Velcro through a visual color guide. The Precast Adjustable Compression Wrap has proved to be safe and effective to treat lower limb lymphedema, but there is little information about its effectiveness in the treatment of the upper limb lymphedema.

The aim is to compare the effectiveness of a precast adjustable compression wrap (Circaid) with the multilayer compression bandages in the treatment of the upper limb lymphedema.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
47
Inclusion Criteria
  • Upper limb lymphedema after axillary lymph node dissection for breast cancer.
  • Lymphedema must affect at least the arm or the forearm.
  • The lymphedema volume excess must be at least 10%
  • The lymphedema must have not been previously treated or have been at least 1 year without treatment.
Exclusion Criteria
  • Bilateral upper limb lymphedema
  • Cognitive or sensorial impairments which could interfere collaboration
  • Plexopathy post radiotherapy
  • Breast cancer in progression Pregnancy or Lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Precast Adjustable Compression WrapPrecast Adjustable Compression Wrap (Circaid)Precast Adjustable Compression Wrap will be adjusted by the physiotherapist each visit
Multilayer Compression BandagesMultilayer Compression BandagesMultilayer Compression Bandages will be adjusted by the physiotherapist each visit
Primary Outcome Measures
NameTimeMethod
Change in the excess of volume of upper limbBaseline to 3 months (10 sessions of treatment)

Change in the excess of volume of the affected upper limb. The excess of volume is the difference in volume between the affected and the unaffected upper limb. The upper limb volumes will be obtained from the perimeters of the upper limbs and applying the truncate cone formula.

Baseline to 2 weeks (10 sessions of treatment). A follow up at 3 months

Secondary Outcome Measures
NameTimeMethod
Changes in pain, heaviness, tightness and hardnessBaseline to 3 months (10 sessions of treatment)

Changes in pain, heaviness, tightness and hardness will be measured by visual analogical scales. Baseline to 2 weeks (10 sessions of treatment). A follow up at 3 months

Changes in skin and lymphedema conditionBaseline to 3 months (10 sessions of treatment)

The skin and lymphedema condition will be evaluated every day along the treatment phase and at 3 months of follow up. Baseline to 2 weeks (10 sessions of treatment). A follow up at 3 months

Number of Participants with Serious and Non-Serious Adverse EventsBaseline to 3 months (10 sessions of treatment)

Collection of adverse effects spontaneously reported by the participants and/or observed by the investigators. In order to evaluate tolerability patients will be asked every day about any discomfort or troubles they could feel. On the other hand, it will be daily recorded how many hours the patient had used the precast adjustable compression wrap or the multilayer compression bandages. Baseline to 2 weeks (10 sessions of treatment). A follow up at 3 months

Trial Locations

Locations (3)

Hospital Vall Hebron

🇪🇸

Barcelona, Spain

Germans Trias i Pujol Hospital

🇪🇸

Badalona, Barcelona, Spain

Hospital Universitari de Bellvitge

🇪🇸

Hospitalet de Llobregat, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath